Latest news with #RussellUSIndexes
Yahoo
2 days ago
- Business
- Yahoo
Neonode Set to Join Russell 2000® Index
STOCKHOLM, June 3, 2025 /PRNewswire/ -- Neonode Inc. (NASDAQ: NEON) (the "Company" or "Neonode") will be added as a member of the U.S. small-cap Russell 2000 Index, effective after the U.S. market opens on June 30 as part of the 2025 Russell indexes reconstitution. Neonode, a provider of touch technology and optical sensing solutions for technologically demanding and regulated industries, debuted on the NASDAQ stock exchange in 2012 under the stock ticker symbol "NEON." Membership in the Russell 2000 Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index. Neonode's stock will also be automatically added to the appropriate growth and value indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. The Russell US Indexes can be used as performance benchmarks, or as the basis for index-linked products including index tracking funds, derivatives and Exchange Traded Funds (ETFs). "Our inclusion in the Russell 2000 Index is an encouraging milestone for Neonode as we position ourselves for future success. We welcome the enhanced visibility it gives us within the investor community and look forward to sharing our progress as we continue our journey toward innovation leadership and sustainable business growth," says Daniel Alexus, President and Chief Executive Officer at Neonode. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. "The Russell indexes have continuously adapted to the evolving dynamic US economy, and it's crucial to fully recalibrate the suite of Russell US Indexes, ensuring the indexes maintain an accurate representation of the market. The transition to a semi-annual reconstitution frequency from 2026 will ensure our indexes continue to represent the market and maintain the purpose of the index as a portfolio benchmark," comments Fiona Bassett, CEO of FTSE Russell, an LSEG Business. For more information on the Russell 2000 Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website. For more information, please contact: Chief Financial OfficerFredrik NihlénE-mail: +46 703 97 21 09 President and Chief Executive OfficerPierre Daniel AlexusE-mail: +46 767 60 29 90 This information was brought to you by Cision The following files are available for download: neonode-set-to-join-russell-2000-20250603 Neonode Set to Join Russell 2000® Index View original content: SOURCE Neonode Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
29-05-2025
- Business
- Miami Herald
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
TAMPA, FLORIDA / ACCESS Newswire / May 29, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, as part of the 2025 Russell US Indexes annual reconstitution. FTSE Russell released the preliminary list of additions and deletions to the Russell 2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected to take effect following the close of the U.S. equity market on Friday, June 27, 2025. The Russell 3000 Index encompasses the 3,000 largest U.S. companies by market capitalization, representing approximately 98% of the investable U.S. equity market. The Russell 2000 Index is a subset of the Russell 3000, measuring the performance of the small-cap segment. These indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. "Wellgistics Health's preliminary inclusion in the Russell 2000 and Russell 3000 indexes marks an important milestone in our company's journey," said Brian Norton, CEO of Wellgistics Health. "This recognition enhances our visibility among the broader investment community, supports increased institutional interest and ownership in our stock, and serves as strong validation of our team's ability to execute on our business plan and drive value to our shareholders." About Wellgistics Health Wellgistics Health, Inc. is a publicly traded healthcare infrastructure company redefining how medications move, are priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a nationwide network of over 6,000 independent pharmacies. Wellgistics Health provides real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment solutions, while equipping pharmacies with integrated financial, clinical, and digital tools. Its end-to-end platform supports a broad range of therapeutic areas from specialty-lite to chronic maintenance medications by eliminating friction, accelerating reimbursements, and enabling direct, transparent connections between manufacturers, providers, pharmacies, and patients. For more information, visit Forward-Looking Statements This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans, including without limitation its plan in connection with certain financings and cryptocurrencies and outlook and actions with respect to incurring future expenses. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at For more information, please contact: Media Contact: media@ Relations: investors@ Investor Relations Contact:Skyline Corporate Communications Group, LLCScott Powell, President1177 Avenue of the Americas, 5th FloorNew York, NY 10036Office: (646) 893-5835Email: info@ SOURCE: Wellgistics Health, Inc.
Associated Press
29-05-2025
- Business
- Associated Press
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
TAMPA, FLORIDA / ACCESS Newswire / May 29, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, as part of the 2025 Russell US Indexes annual reconstitution. FTSE Russell released the preliminary list of additions and deletions to the Russell 2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected to take effect following the close of the U.S. equity market on Friday, June 27, 2025. The Russell 3000 Index encompasses the 3,000 largest U.S. companies by market capitalization, representing approximately 98% of the investable U.S. equity market. The Russell 2000 Index is a subset of the Russell 3000, measuring the performance of the small-cap segment. These indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. 'Wellgistics Health's preliminary inclusion in the Russell 2000 and Russell 3000 indexes marks an important milestone in our company's journey,' said Brian Norton, CEO of Wellgistics Health. 'This recognition enhances our visibility among the broader investment community, supports increased institutional interest and ownership in our stock, and serves as strong validation of our team's ability to execute on our business plan and drive value to our shareholders.' About Wellgistics Health Wellgistics Health, Inc. is a publicly traded healthcare infrastructure company redefining how medications move, are priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a nationwide network of over 6,000 independent pharmacies. Wellgistics Health provides real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment solutions, while equipping pharmacies with integrated financial, clinical, and digital tools. Its end-to-end platform supports a broad range of therapeutic areas from specialty-lite to chronic maintenance medications by eliminating friction, accelerating reimbursements, and enabling direct, transparent connections between manufacturers, providers, pharmacies, and patients. For more information, visit Forward-Looking Statements This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as 'may, 'will, 'intend,' 'should,' 'believe,' 'expect,' 'anticipate,' 'project,' 'estimate' or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans, including without limitation its plan in connection with certain financings and cryptocurrencies and outlook and actions with respect to incurring future expenses. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at For more information, please contact: Media Contact: [email protected] Investor Relations: [email protected] Investor Relations Contact: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, NY 10036 Office: (646) 893-5835 Email: [email protected] SOURCE: Wellgistics Health, Inc. press release
Business Wire
28-05-2025
- Business
- Business Wire
Safe Pro Group Set to Join Russell Microcap ® Index
AVENTURA, Fla.--(BUSINESS WIRE)-- Safe Pro Group Inc. (Nasdaq: SPAI) ("Safe Pro" or the "Company"), a leading provider of artificial intelligence (AI)-driven security solutions, is set to join the Russell Microcap® Index at the conclusion of the 2025 Russell indexes annual reconstitution, effective after the US market opens on June 30, 2025, according to a preliminary list of additions posted on May 23, 2025. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30, 2025, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. 'Joining the Russell Microcap® Index marks another milestone for Safe Pro Group, reflecting the progress we have made in advancing our mission to deliver AI-powered security solutions for defense and humanitarian missions around the world. Our unique combination of technologies can help save lives and support the restoration of critical infrastructure and valuable agricultural land contaminated by explosive threats as a result of war,' said Dan Erdberg, Chairman and CEO of Safe Pro Group Inc. 'We look forward to our inclusion in the Russell Microcap® index which can bring greater investor awareness to Safe Pro at this pivotal time as we continue to scale our technology, expand our market reach, and drive innovation and long-term value for all our stakeholders.' Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. For more information on the Russell Microcap® Index and the Russell indexes reconstitution, go to the 'Russell Reconstitution' section on the FTSE Russell website. For more information about Safe Pro Group, its subsidiaries, and technologies, please visit and connect with us on LinkedIn, Facebook, X and Instagram. About Safe Pro Group Inc. Safe Pro Group is a leading provider of artificial intelligence (AI) solutions specializing in drone imagery processing leveraging commercially available "off-the-shelf" drones with its proprietary machine learning and computer vision technology to enable rapid identification of explosives threats, providing a much safer and more efficient alternative to traditional human-based analysis methods. Built on a cloud-based ecosystem and powered by Amazon Web Services (AWS), Safe Pro Group's scalable platform is targeting multiple markets that include commercial, government, law enforcement and humanitarian sectors where its Safe Pro AI software, Safe-Pro USA protective gear and Airborne Response drone-based services can work in synergy to deliver safety and operational efficiency. For more information on Safe Pro Group Inc., please visit About FTSE Russell, an LSEG Business FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering. FTSE Russell is wholly owned by London Stock Exchange Group. Forward-Looking Statements Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements relate to future events, future expectations, plans and prospects. Forward-looking statements in this press release include, without limitation, Safe Pro's inclusion in the Russell Microcap® index and its ability to develop and sell its technology and services. Although Safe Pro Group believes the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Safe Pro Group has attempted to identify forward-looking statements by terminology including ''believes,'' ''estimates,'' ''anticipates,'' ''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,'' ''might,'' ''will,'' ''should,'' ''approximately'' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including market and other conditions. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth under Item 1A. in the Company's most recently filed Form 10-K and updated from time to time in the Company's Form 10-Q filings and in other filings with the Securities and Exchange Commission (the 'SEC'), copies of which may be obtained from the SEC's website at The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
Yahoo
27-05-2025
- Business
- Yahoo
Electromed, Inc. to Join Russell 2000® and Russell 3000® Indexes
NEW PRAGUE, Minn., May 27, 2025--(BUSINESS WIRE)--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that the Company will join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index, effective after the close of U.S. equity markets on June 27, 2025, as part of their 2025 annual reconstitution, according to a preliminary list of additions posted by FTSE Russell on May 23, 2025. "We are pleased that Electromed is joining these important market indices, which serve as leading benchmarks for institutional investors and as the basis for numerous index-linked financial products," said Jim Cunniff, Electromed's President and Chief Executive Officer. "This is an important milestone in Electromed's growth, and a testament to the significant progress Electromed has made in enhancing shareholder value over the past year." The broad-market Russell 3000 Index includes the largest 3,000 U.S. public companies by market capitalization. The Russell 2000 Index is a subset of the broader Russell 3000 Index limited to small-cap companies. Both are widely used by investment managers and institutional investors as the basis for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell US Indexes. Russell US Indexes are part of FTSE Russell's suite of index offerings. For more information on the Russell 2000® and Russell 3000® Indexes and the Russell indexes reconstitution, visit the "Russell Reconstitution" section on the FTSE Russell website. About Electromed, Inc. Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at View source version on Contacts Brad Nagel, Chief Financial Officer(952) 758-9299investorrelations@ Mike Cavanaugh, Investor RelationsICR Healthcare(617)
